NCT07076238View on ClinicalTrials.gov

Biomarker Investigation of Response to Bacteriophage Treatment for Bacterial Infection

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 25, 2025

Primary Completion Date

June 25, 2030

Study Completion Date

June 25, 2032

Conditions
Nontuberculous Mycobacterial Lung Disease
Interventions
BIOLOGICAL

Bacteriophage Treatment

Participants who have a positive match for their NTM isolate will start on mycobacteriophage treatment per prescribed treatment regimen.

Trial Locations (1)

10016

RECRUITING

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT07076238 - Biomarker Investigation of Response to Bacteriophage Treatment for Bacterial Infection | Biotech Hunter | Biotech Hunter